– NETHERLANDS, Venlo – QIAGEN N.V. (NYSE: QGEN / FRA: QIA) announced the nomination of Stephen H. Rusckowski to succeed Lawrence Rosen as Chairman of the Supervisory Board following its AGM on June 26, 2025, to succeed Mr. Rosen, who will step down from the Supervisory Board.
Additionally, Prof. Dr. Elaine Mardis will not stand for re-election to the Supervisory Board.
Mr. Rusckowski joined the Supervisory Board in 2023 and serves as Chair of the Nomination & Governance Committee. He is a recognized international healthcare industry leader and most recently served as Chairman, President and CEO of Quest Diagnostics and previously as CEO of Philips Healthcare.
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics software and knowledge bases can be used to interpret data to find actionable insights. Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&, D and industrial applications, primarily forensics) and Molecular Diagnostics for clinical healthcare. As of March 31, 2025, QIAGEN employed approximately 5,700 people in over 35 locations worldwide.
For more: https://www.qiagen.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.